Medication Use Evaluation of Dronedarone in Comparison to Amiodarone
Amiodarone is the most effective rhythm-control for atrial fibrillation, but produces serious potential side effects. Dronedarone was designed to eliminate amiodarone toxicities, but increased the risk of mortality in clinical trials. This medication use evaluation compares one year of dronedarone u...
Κύριοι συγγραφείς: | Adam Corey, Nita Johnston |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
University of Minnesota Libraries Publishing
2016-12-01
|
Σειρά: | INNOVATIONS in Pharmacy |
Θέματα: | |
Διαθέσιμο Online: | https://pubs.lib.umn.edu/index.php/innovations/article/view/480 |
Παρόμοια τεκμήρια
-
Comparison of Efficacy and Safety Between Dronedarone and Amiodarone Used During the Blind Period in Patients with Atrial Fibrillation After Catheter Ablation
ανά: Li Y, κ.ά.
Έκδοση: (2023-12-01) -
Cost-Effectiveness of Dronedarone and Amiodarone for the Treatment of Chinese Patients With Atrial Fibrillation
ανά: Mengran Zhang, κ.ά.
Έκδοση: (2021-08-01) -
Dronedarone and Amiodarone Induce Dyslipidemia and Thyroid Dysfunction in Rats
ανά: Li-Qin Jiang, κ.ά.
Έκδοση: (2016-05-01) -
Managing atrial fibrillation in the elderly: critical appraisal of dronedarone
ανά: Trigo P, κ.ά.
Έκδοση: (2011-12-01) -
Dronedarone — an antiarrythmic agent with new potential for atrial fibrillation treatment
ανά: M. Yu. Gilyarov, κ.ά.
Έκδοση: (2010-12-01)